
|Articles|August 24, 2022
Multidisciplinary Management of Patients with Basal Cell Carcinoma
This publication highlights clinical perspectives on current treatment patterns in BCC, key findings from clinical trials, factors that influence clinical decision making, and opportunities for the development of novel therapies for this patient population.
Latest CME
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5




































